🏥 HEALTH - Congratulations Johnson & Johnson, for receiving emergency FDA approval status on your vaccine for being 66% effective. Not 66% effective at preventing infection, but the 66% less chance of moderate, severe, or critical COVID-19 infections. You are well on your way to recooping the $6 billion you paid out in lawsuits to settle your role in our nation's opioid crisis and, as you've learned from lawsuits, the federal government protects you from all liability on vaccines and you cannot be sued. #Phama

"The efficacy of the Johnson & Johnson vaccine against moderate to severe/critical Covid-19 across all geographic areas was 66.9% at least 14 days after the single dose vaccination and 66.1% at least 28 days after vaccination, a new analysis meant to brief the FDA's Vaccines and Related Biological Products Advisory Committee said."

Full Article
@intelops